Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct - sprookjes - yvandenbroek - TriplyDB

Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct

Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct

http://www.wikidata.org/entity/Q34038519

about

Dendrimer Prodrugs Multivalent polymers for drug delivery and imaging: the challenges of conjugation Synthesis and properties of star-comb polymers and their doxorubicin conjugates.Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation.Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.Biotargeted nanomedicines for cancer: six tenets before you begin Macromolecules as taxane delivery systems.Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties.Computational design principles for the discovery of bioactive dendrimers: [s]-triazines and other examples.Dendrimers for theranostic applications.Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.Dendrimers in combination with natural products and analogues as anti-cancer agents.

P2860

Q26743392-594FB76B-264F-4E23-A645-1AEE1665A0A7 Q27692689-21E38C4C-0D10-485A-9313-273407E11BC3 Q35003680-D0E74F09-B083-4244-93E3-BC272DF2F03C Q35552351-163F37E2-8714-4EE3-BB0E-B752B17C28A5 Q36690711-3EFD7E10-B106-4F0D-A86E-749C8E3B1B47 Q36814280-59CFC6F7-9F8A-48B7-B99E-EC9B7338B6A1 Q37818236-57739143-D6BD-49D6-BF54-DFD3085723D9 Q37886750-89F9570A-50CF-4344-B23B-3445E708F25C Q37939967-88946710-CF62-4D49-AE12-5B49AD2D3386 Q38119267-5D9AB3C4-7D26-4F3C-8163-6447CE439A2A Q38542021-3921900C-91C7-4855-A10E-42B02C5A8E20 Q38846339-0601B155-FB2E-45E7-B4D3-26CF1BEBDC5B Q39672604-F5FE3439-0E97-4F0B-967A-5166FD6B190E Q47333126-DA1D97BB-7BA1-4455-BEF6-99A18D1A765E

P2860

Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct

http://www.wikidata.org/entity/Q34038519

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Biological assessment of triaz ...... EGylated, paclitaxel construct

@ast

Biological assessment of triaz ...... EGylated, paclitaxel construct

@en

Biological assessment of triaz ...... EGylated, paclitaxel construct

@nl

type

label

Biological assessment of triaz ...... EGylated, paclitaxel construct

@ast

Biological assessment of triaz ...... EGylated, paclitaxel construct

@en

Biological assessment of triaz ...... EGylated, paclitaxel construct

@nl

prefLabel

Biological assessment of triaz ...... EGylated, paclitaxel construct

@ast

Biological assessment of triaz ...... EGylated, paclitaxel construct

@en

Biological assessment of triaz ...... EGylated, paclitaxel construct

@nl

P1433

Q34038519-D91FB999-A062-480E-BD72-CA90A533FC38

P1476

Q34038519-8D2B5E9E-E2A7-4311-A56E-545EE1785944

P2093

Q34038519-374021AE-AAB3-4A10-8D10-453A18258178

Q34038519-4A631061-3A94-4193-8E8E-28A4EEFC21F8

Q34038519-A017212F-C64D-475A-8188-731E0F56E80D

Q34038519-A075A342-4D57-4E81-A6D8-EF1F956690E1

Q34038519-CEECCB21-28CC-491E-B5B6-AB650E76595B

Q34038519-E869F271-147A-41AE-BFAF-89F3D2F9E9F7

Q34038519-EDC6B621-0FD4-40CD-B702-55A66F181FFC

Q34038519-F329D90B-DEB0-47C8-9CEE-413A564DDC18

Q34038519-F84BA746-CAB8-4ED4-8EC4-3E6B0673E8A3

P2860

Q34038519-014B0D2E-D245-4BDB-9706-787C09FBCDE0

Q34038519-04DB24B0-54D5-4583-B707-7E2923963F12

Q34038519-24B637DA-EB11-46AB-BD03-5D4C3BB8DBE8

Q34038519-304E3CB0-3DBA-4BFB-A8A8-03AC21A5F0FB

Q34038519-30FF71C0-9A51-4813-B565-902096E0E5F7

Q34038519-4029368C-213B-4BEA-87FC-A156319F4E0A

Q34038519-4057AA2A-0182-4356-8481-64B00789DE24

Q34038519-43F90CCA-4F3A-421B-99BA-A1D4763A0E91

Q34038519-46E655A3-FAD0-4CFC-9E2C-2CD108195B61

Q34038519-4C669815-7455-4414-956B-951223EE18BE

P304

Q34038519-50E647F0-3C58-4DCD-94A4-52C6B84F6A0E

P31

Q34038519-BDEFA194-0DB4-4F6B-A0D3-41EDF684EBA3

P356

Q34038519-AC7B1E55-F862-49E8-81F9-F9D8F09EC04E

P407

Q34038519-21491FA0-34B1-485F-B10F-D7C1009CA4A6

P433

Q34038519-E9105412-250A-406E-84BE-33747BD8E324

P478

Q34038519-E8002446-5967-4C53-A33F-DDF30558374F

P50

Q34038519-1FF83F56-DA02-4E72-BF41-4FD9AA7DE1C4

P577

Q34038519-27AC8898-1AD2-4111-9145-6F3C3F64A223

P5875

Q34038519-24C94E53-BBE2-4763-9D2B-912A7B677CD4

P698

Q34038519-8E146206-15FB-4337-A9CE-AA4FE0080008

P932

Q34038519-7A04DC97-ABB0-4379-B382-6B1FAA81A177

P356

P1433

Molecular Pharmaceutics

P1476

Biological assessment of triaz ...... EGylated, paclitaxel construct

@en

P2093

Anil K Patri

http://www.w3.org/2001/XMLSchema#string

Eric E Simanek

http://www.w3.org/2001/XMLSchema#string

Jiwen Zheng

http://www.w3.org/2001/XMLSchema#string

Jongdoo Lim

http://www.w3.org/2001/XMLSchema#string

Marina Dobrovolskaia

http://www.w3.org/2001/XMLSchema#string

Pavan P Adiseshaiah

http://www.w3.org/2001/XMLSchema#string

Stephan Stern

http://www.w3.org/2001/XMLSchema#string

Su-Tang Lo

http://www.w3.org/2001/XMLSchema#string

Xiankai Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Kilogram-scale synthesis of a second-generation dendrimer based on 1,3,5-triazine using green and industrially compatible methods with a single chromatographic step

Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity

Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.

Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery.

Synthesis and manipulation of orthogonally protected dendrimers: building blocks for library synthesis.

Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture.

Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.

Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.

A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.

Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications.

P304

993-1006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP100104X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey D Clogston

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44610469

http://www.w3.org/2001/XMLSchema#string

P698

20481608

http://www.w3.org/2001/XMLSchema#string

P932

2914493

http://www.w3.org/2001/XMLSchema#string